Cambridge Trust CO Corcept Therapeutics Inc Transaction History

Cambridge Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 27, 2021	SELL	$16.78 - $27.3 $33,560 - $54,600	-2,000 Reduced 6.21%	30,200 $790,000
Q4 2019 Feb 04, 2020	SELL	$12.06 - $16.96 $43,416 - $61,056	-3,600 Reduced 10.06%	32,200 $390,000
Q4 2017 Jan 24, 2018	SELL	$15.77 - $20.72 $66,234 - $87,024	-4,200 Reduced 10.5%	35,800 $0
Q3 2017 Nov 02, 2017	BUY	$12.3 - $19.3 $492,000 - $772,000	40,000	40,000 $0

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

Stay updated on Cambridge Trust CO with notifications on news.